Comparison of Early Response to Selumetinib Therapy in Adolescents and Children With NF1-related Plexiform Neurofibromas

JAGODA STYCZYŃSKA; AGATA MARJAŃSKA; AGNIESZKA JATCZAK-GACA; MAREK KARWACKI; JUSTYNA WALENCIAK; KATARZYNA GARUS; KATARZYNA BILSKA; AGNIESZKA MIZIA-MALARZ; WANDA BADOWSKA; DOROTA SŁAWIŃSKA; JADWIGA WĘCŁAWEK-TOMPOL; RADOSŁAW CHABER; EWA BIEŃ; MICHALINA JEZIERSKA; GRAŻYNA KAROLCZYK; JOLANTA SKALSKA-SADOWSKA; JAN STYCZYŃSKI

doi:10.21873/invivo.14312

Article Information

vol. 40 no. 3 1621-1627

DOI

https://doi.org/10.21873/invivo.14312

PMID

42049404

Published By

International Institute of Anticancer Research

Print ISSN

0258-851X

Online ISSN

1791-7549

History

Received January 9, 2026
Revision received February 9, 2026
Accepted February 11, 2026
Published online April 28, 2026.

Copyright © 2026 The Author(s). Published by the International Institute of Anticancer Research. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Author Information

JAGODA STYCZYŃSKA¹ ⇑,
AGATA MARJAŃSKA¹,
AGNIESZKA JATCZAK-GACA¹,
MAREK KARWACKI²,
JUSTYNA WALENCIAK³,
KATARZYNA GARUS⁴,
KATARZYNA BILSKA⁵,
AGNIESZKA MIZIA-MALARZ⁶,
WANDA BADOWSKA⁷,
DOROTA SŁAWIŃSKA⁸,
JADWIGA WĘCŁAWEK-TOMPOL⁹,
RADOSŁAW CHABER¹⁰,
EWA BIEŃ¹¹,
MICHALINA JEZIERSKA¹¹,
GRAŻYNA KAROLCZYK¹²,
JOLANTA SKALSKA-SADOWSKA¹³ and
JAN STYCZYŃSKI¹

¹Department of Pediatric Hematology, Oncology, Immunology and Transplantology, Collegium Medicum, Nicolaus Copernicus University Torun, Jurasz University Hospital, Bydgoszcz, Poland;
²Department of Pediatric Hematology and Oncology, Clinical Transplantology and Pediatrics, Medical University of Warsaw, Warsaw, Poland;
³Department of Pediatrics, Oncology and Hematology, Medical University, Łódź, Poland;
⁴Department of Pediatric Oncology and Hematology, Institute of Pediatrics, Jagiellonian University Medical College, Kraków, Poland;
⁵Department of Oncology and Surgical Oncology for Children and Youth, Institute of Mother and Child, Warsaw, Poland;
⁶Department of Oncology, Hematology and Chemotherapy, Division of Pediatrics, Medical University of Silesia, Upper Silesian Child Health Centre, Katowice, Poland;
⁷Department of Pediatrics and Hematology and Oncology, Province Children’s Hospital, Olsztyn, Poland;
⁸Department of Pediatric Haematology and Oncology and Transplantology, Medical University, Lublin, Poland;
⁹Department of Pediatric Hematology/Oncology and BMT, Medical University, Wrocław, Poland;
¹⁰Department of Pediatrics, Institute of Medical Sciences, Collegium Medicum, University of Rzeszów, Rzeszów, Poland;
¹¹Department of Pediatrics, Hematology and Oncology, Medical University, Gdańsk, Poland;
¹²Department of Pediatric Oncology and Hematology, Children’s Hospital in Kielce, Kielce, Poland;
¹³Department of Pediatric Oncology, Hematology and Transplantology, Poznań University of Medical Sciences, Poznań, Poland

Jagoda Styczyńska, Department of Pediatric Hematology, Oncology, Immunology and Transplantology, Collegium Medicum, Nicolaus Copernicus University, Antoni Jurasz University Hospital No. 1, ul. Sklodowskiej-Curie 9, 85-094 Bydgoszcz, Poland. Tel: +48 525854860, e-mail: jagasadlok{at}gmail.com

View Full Text